Drugs that are being used to halt puberty in gender-confused youth have been linked to thousands of adult deaths, government data show.
The Food & Drug Administration has recorded thousands of deaths associated with Lupron, a puberty-blocking drug that is routinely used to treat prostate cancer in men and endometriosis in women. Adverse complications related to its use include breast disorders, malignant neoplasms, and psychiatric and nervous disorders.
Lupron — and other drugs in its class — significantly alters the hormone levels in the body and has been documented to contribute to blood clots and other cardiovascular complications, as well as brittle bones and faulty joints.
Between 2004 and June 30 of this year, the FDA documented 33,478 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 19,054 reactions were considered “serious,” including 6,056 deaths.
The figure rises when factoring in the total number of adverse reactions logged by the FDA since 1984. In total, there have been 40,764 adverse reactions, 25,513 of those were considered “serious,” among those were 6,370 deaths.
Lupron is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose. The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age.
When injected into a physically healthy body, the drug interrupts a normally-functioning endocrine system, yielding hypogonadotropic hypogonadism, according to Michael Laidlaw, a Rocklin, California-based endocrinologist.
“It’s a serious condition that endocrinologists would normally diagnose and treat because it interferes with development, but in [gender dysphoria] cases they’re inducing this disease state,” he said in an interview with the National Catholic Register.
According to the annual report of AbbVie, the company that produces Lupron, sales of the drug were approximately $669 million in 2017 in the United States alone.
Full story at The Christian Post.
One needs to read the Christian Post article to learn that use of Lupron for ‘gender confused’ prersons is ‘off label’ or NOT approved.
This is insane, barbaric and unimaginably cruel! Those of us who acknowledge biological facts are haters and “progressive” gender ideologues promote this (and have all of us pay for it)! I’ve been on Lupron and had to read all the warnings about side effects. Thanks be to God, my cancer is gone, but, I’m still experiencing some of the side effects well over a year after stopping Lupron. It’s a prostate cancer drug. Giving this to children is unconscionable! God bless, heal and deliver children, and others, with gender dysphoria! As a society, we’re not helping them by further injuring and possibly even killing them.
This should never been given to adolescents to “change their gender”, but it could be beneficial to older cancer patients. One side effect might be impotence, but I am not that familiar with Leuprolide
It might be safe for a very short time for girls who have started their menstrual cycle too early. I had a younger cousin who started menses at about five to eight – way too early. They gave her something,to stop it, but I am not sure what it was, and that was way back in the 1950’s, so it was not Leuprolide.
I myself took Arimedex, or the generic brand, an experimental drug from Europe that is given to post menopausal women for cancer. Weight gain is a side effect.
Correction to spelling: that should be “Arimidex”. that I took.
Also, I am not a healthcare provider, so the men who have taken Leuprolide and healthcare providers and researchers know more about the side effects than I do.
In a more sane society any person whose dispensed this drug would be thrown in prison
This drug has saved the lives of hundreds of thousands of men with prostate cancer. Why would you want to throw their doctors into prison?
Even the pro-transgender World Professional Association for Transgender Health stated, “no controlled clinical trials of any feminizing/masculinizing hormone regimen have been conducted to evaluate safety or efficacy in producing physical transition.” This shows disregard for those suffering from gender dysphoria, not compassion. (Of course, I can think of no objections to using Lupron to treat men with prostate cancer.)